Head-to-Head

Abbott Laboratories vs. Ocular Therapeutix, Inc.

ABT

Abbott Laboratories

$96.69 -2.17%

VS OCUL

Ocular Therapeutix, Inc.

$7.29 -4.95%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTOCUL
Market Cap $171.01 billion $1.68 billion

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTOCUL
Dividend Yield 2.61% —

ABT and OCUL split the dividend factors evenly.

Risk & Sentiment

ABTOCUL
Short Interest 0.57% 1.47%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, OCUL overview, OCUL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.